A human stroke drug, fast-tracked by the Food and Drug Administration and soon entering Phase 3 clinical trials, shows intriguing signs that it might also be a safe and powerful defense against Alzheimer's and other forms ...
Dec 1, 2021
0
251
Racial and ethnic disparities in the quality of care nursing home residents receive is a serious and known problem in the United States. To increase overall patient quality of care, the Centers for Medicare & Medicaid Services ...
Oct 4, 2021
0
14
Researchers have identified a new treatment candidate that appears to not only halt neurodegenerative symptoms in mouse models of dementia and Alzheimer's disease, but also reverse the effects of the disorders.
Jun 29, 2021
1
3
The use of statin therapy in adults 65 years old or older is not associated with incident dementia, mild cognitive impairment (MCI) or decline in individual cognition domains, according to a study published in the Journal ...
Jun 21, 2021
0
12
Non-drug therapies as good as or better than drugs for treating depression in people with dementia
Mar 24, 2021
0
7
People over 65 shouldn't take three or more medicines that act on their brain and nervous system, experts strongly warn, because the drugs can interact and raise the risk of everything from falls to overdoses to memory issues.
Mar 9, 2021
0
59
A study led by Case Western Reserve University researchers found that patients with dementia were at a significantly increased risk for COVID-19—and the risk was higher still for African Americans with dementia.
Feb 9, 2021
0
0
What percent of patients with Alzheimer's Disease (AD) currently have severe dementia? Do more people have mild disease? Or are the majority suffering with moderate dementia? A new study using data from the Framingham Heart ...
Jan 13, 2021
0
2
With much of the U.K. just emerging from its second coronavirus 'lockdown' into new tiers, the amount of social contact we are able to have is still limited. Among the worst affected are people living in the country's care ...
Dec 3, 2020
0
0
A gut hormone, ghrelin, is a key regulator of new nerve cells in the adult brain, a Swansea-led research team has discovered. It could help pave the way for new drugs to treat dementia in patients with Parkinson's Disease.
Oct 21, 2020
0
20
